Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.

Pitot, H C

Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug 1997 - 2910-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.1997.15.8.2910 doi


Adenocarcinoma--drug therapy
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents, Phytogenic--adverse effects
Camptothecin--adverse effects
Colorectal Neoplasms--pathology
Female
Fluorouracil--therapeutic use
Humans
Infusions, Intravenous
Irinotecan
Male
Middle Aged